Inhibikase Therapeutics Inc. Common Stock (IKT)
FairStock Score: 32/100 — RISKY
| Current Price | $1.94 |
| Market Cap | $25,54,83,152 |
| P/E Ratio | — |
| ROE | -36.04% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology